despite a moderate reduction in inflammatory lipid mediators by dietary n-3 fatty acids and limited morphological improvement in chronic inflammatory bowel disease , the clinical benefit seems to be confined to patients with ulcerative colitis .
C0021853
bowel
C0009324
ulcerative colitis